Rule-Based Turkish Text Summarizer (RB-TTS) by BIRANT, C. C., AKTAS, O.

Get full text

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status. by Jarius, S, Paul, F, Franciotta, D, Aktas, O, Hohlfeld, R, Zipp, F, Vincent, A

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. by Paul, F, Jarius, S, Aktas, O, Bluthner, M, Bauer, O, Appelhans, H, Franciotta, D, Bergamaschi, R, Littleton, E, Palace, J, Seelig, H, Hohlfeld, R, Vincent, A, Zipp, F

Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study by Gunen H, Yilmaz M, Aktas O, Ergun P, Ortakoylu MG, Demir A, Cetinkaya P, Gurgun A, Otlu M, Cilli A, Yilmaz U, Kokturk N, Candemir I, Yakar HI, Ar I, Konya A

Get full text

Racial differences in neuromyelitis optica spectrum disorder by Kim, S, Mealy, M, Levy, M, Schmidt, F, Ruprecht, K, Paul, F, Ringelstein, M, Aktas, O, Hartung, H, Asgari, N, Tsz-Ching, J, Siritho, S, Prayoonwiwat, N, Shin, H, Hyun, J, Han, M, Leite, M, Palace, J, Kim, H

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing by Jarius, S, Paul, F, Aktas, O, Asgari, N, Dale, RC, De Seze, J, Franciotta, D, Fujihara, K, Jacob, A, Kim, HJ, Kleiter, I, Kümpfel, T, Levy, M, Palace, J, Ruprecht, K, Saiz, A, Trebst, C, Weinshenker, BG, Wildemann, B

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial by Cree, BAC, Bennett, JL, Kim, HJ, Weinshenker, BG, Pittock, SJ, Wingerchuk, DM, Fujihara, K, Paul, F, Cutter, GR, Marignier, R, Green, AJ, Aktas, O, Hartung, H-P, Lublin, FD, Drappa, J, Barron, G, Madani, S, Ratchford, JN, She, D, Cimbora, D, Katz, E

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. by Collongues, N, Marignier, R, Jacob, A, Leite, M, Siva, A, Paul, F, Zephir, H, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J

Characterization of NMO and NMOSD Patients with a Late Onset by Collongues, N, Marignier, R, Jacob, A, Siva, A, Paul, F, Zephir, H, Leite, M, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J